![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C14H17F3NO9P |
Molar mass | 431.257 g·mol−1 |
3D model ( JSmol) | |
| |
|
LSP2-9166 is a drug which acts as a selective agonist for the group III metabotropic glutamate receptors, with a reasonably potent EC50 of 70nM at mGluR4 and 220nM at mGluR7, and weaker activity of 1380nM at mGluR6 and 4800nM at mGluR8. [1] It has anticonvulsant effects in animal studies, [2] [3] and reduces self-administration of various addictive drugs. [4] [5] [6]
![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C14H17F3NO9P |
Molar mass | 431.257 g·mol−1 |
3D model ( JSmol) | |
| |
|
LSP2-9166 is a drug which acts as a selective agonist for the group III metabotropic glutamate receptors, with a reasonably potent EC50 of 70nM at mGluR4 and 220nM at mGluR7, and weaker activity of 1380nM at mGluR6 and 4800nM at mGluR8. [1] It has anticonvulsant effects in animal studies, [2] [3] and reduces self-administration of various addictive drugs. [4] [5] [6]